Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Lymphomatoid Papulosis Type B in a Patient with Crohn's Disease Treated with TNF-Alpha Inhibitors Infliximab and Adalimumab.

Medvecz M, Kiss N, Hársing J, Kuroli E, Hegede G, Csomor J, Kárpáti S, Marschalkó M.

Acta Dermatovenerol Croat. 2019 Sep;27(3):202-204.

PMID:
31542070
2.

Calreticulin mutation specific CAL2 immunohistochemistry accurately identifies rare calreticulin mutations in myeloproliferative neoplasms.

Mózes R, Gángó A, Sulák A, Vida L, Reiniger L, Timár B, Krenács T, Alizadeh H, Masszi T, Gaál-Weisinger J, Demeter J, Csomor J, Matolcsy A, Kajtár B, Bödör C.

Pathology. 2019 Apr;51(3):301-307. doi: 10.1016/j.pathol.2018.11.007. Epub 2018 Dec 31.

PMID:
30606612
3.

[Change in paradigm in the treatment of pediatric acquired bone marrow failure syndromes in Hungary].

Kállay K, Csomor J, Ádám E, Bödör C, Kassa C, Simon R, Kovács G, Péter G, Ottóffy G, Bartyik K, Kiss C, Masát P, Réti M, Tóth B, Kriván G.

Orv Hetil. 2018 Oct;159(42):1710-1719. doi: 10.1556/650.2018.31171. Hungarian.

PMID:
30334483
4.

The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.

Scarisbrick JJ, Quaglino P, Prince HM, Papadavid E, Hodak E, Bagot M, Servitje O, Berti E, Ortiz-Romero P, Stadler R, Patsatsi A, Knobler R, Guenova E, Child F, Whittaker S, Nikolaou V, Tomasini C, Amitay I, Prag Naveh H, Ram-Wolff C, Battistella M, Alberti-Violetti S, Stranzenbach R, Gargallo V, Muniesa C, Koletsa T, Jonak C, Porkert S, Mitteldorf C, Estrach T, Combalia A, Marschalko M, Csomor J, Szepesi A, Cozzio A, Dummer R, Pimpinelli N, Grandi V, Beylot-Barry M, Pham-Ledard A, Wobser M, Geissinger E, Wehkamp U, Weichenthal M, Cowan R, Parry E, Harris J, Wachsmuth R, Turner D, Bates A, Healy E, Trautinger F, Latzka J, Yoo J, Vydianath B, Amel-Kashipaz R, Marinos L, Oikonomidi A, Stratigos A, Vignon-Pennamen MD, Battistella M, Climent F, Gonzalez-Barca E, Georgiou E, Senetta R, Zinzani P, Vakeva L, Ranki A, Busschots AM, Hauben E, Bervoets A, Woei-A-Jin FJSH, Matin R, Collins G, Weatherhead S, Frew J, Bayne M, Dunnill G, McKay P, Arumainathan A, Azurdia R, Benstead K, Twigger R, Rieger K, Brown R, Sanches JA, Miyashiro D, Akilov O, McCann S, Sahi H, Damasco FM, Querfeld C, Folkes A, Bur C, Klemke CD, Enz P, Pujol R, Quint K, Geskin L, Hong E, Evison F, Vermeer M, Cerroni L, Kempf W, Kim Y, Willemze R.

Br J Dermatol. 2019 Aug;181(2):350-357. doi: 10.1111/bjd.17258. Epub 2018 Nov 25.

PMID:
30267549
5.

Spatial clonal evolution leading to ibrutinib resistance and disease progression in chronic lymphocytic leukemia.

Kiss R, Alpár D, Gángó A, Nagy N, Eyupoglu E, Aczél D, Matolcsy A, Csomor J, Mátrai Z, Bödör C.

Haematologica. 2019 Jan;104(1):e38-e41. doi: 10.3324/haematol.2018.202085. Epub 2018 Sep 27. No abstract available.

6.

Extramedullary Plasmacytoma of the Pancreas Complicated with Left-Sided Portal Hypertension-a Case Report and Literature Review.

Csomor J, Bunganič B, Dvořáková D, Hříbek P, Kmochová K, Campr V, Tučková I, Šálek C, Urbánek P, Zavoral M.

J Gastrointest Cancer. 2018 Jul 23. doi: 10.1007/s12029-018-0146-8. [Epub ahead of print] No abstract available.

PMID:
30033507
7.

Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.

Gángó A, Bátai B, Varga M, Kapczár D, Papp G, Marschalkó M, Kuroli E, Schneider T, Csomor J, Matolcsy A, Bödör C, Szepesi Á.

Virchows Arch. 2018 Oct;473(4):453-462. doi: 10.1007/s00428-018-2384-3. Epub 2018 Jun 1.

PMID:
29858685
8.

[Systemic mastocytosis with progressive disease course].

Várkonyi J, Szombath G, Vályi-Nagy A, Csomor J, Egedi K, Kovalszky I, Tölgyesi K, Szerafin L, Tóth L, Soós G, Masszi T.

Orv Hetil. 2018 Feb;159(5):192-196. doi: 10.1556/650.2018.30978. Hungarian.

PMID:
29376426
9.

Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms.

Gángó A, Mózes R, Boha Z, Kajtár B, Timár B, Király PA, Kiss R, Fésüs V, Nagy N, Demeter J, Körösmezey G, Borbényi Z, Marton I, Szőke A, Masszi T, Farkas P, Várkonyi J, Plander M, Pósfai É, Egyed M, Pál K, Radványi G, Hamed A, Csomor J, Matolcsy A, Alpár D, Bödör C.

Leuk Res. 2018 Feb;65:42-48. doi: 10.1016/j.leukres.2017.12.005. Epub 2018 Jan 2.

PMID:
29306106
10.

[Diagnosis of early pancreatic cancer and precursor lesions].

Hrůzová M, Bunganič B, Csomor J, Zavoral M, Bělina F, Habartová L, Setnička V.

Rozhl Chir. Fall 2017;96(9):369-374. Czech.

PMID:
29063770
11.

DIABETIC KETOACIDOSIS WITH AN ACUTE ABDOMEN AS A FIRST MANIFESTATION OF TYPE 1 DIABETES MELLITUS.

Csomor J, Jirkovska J, Vedralova L, Solar S, Grega T, Urbanek P, Zavoral M.

Acta Endocrinol (Buchar). 2017 Oct-Dec;13(4):509-511. doi: 10.4183/aeb.2017.509.

12.

Recurrent somatic JAK-STAT pathway variants within a RUNX1-mutated pedigree.

Tawana K, Wang J, Király PA, Kállay K, Benyó G, Zombori M, Csomor J, Al Seraihi A, Rio-Machin A, Matolcsy A, Chelala C, Cavenagh J, Fitzgibbon J, Bödör C.

Eur J Hum Genet. 2017 Aug;25(8):1020-1024. doi: 10.1038/ejhg.2017.80. Epub 2017 May 17.

13.

Propofol-induced acute pancreatitis.

Csomor J, Murínová I, Broulíková K, Kučerka O, Sedloň P, Jarošek J, Urbánek P, Zavoral M.

J Clin Pharm Ther. 2017 Aug;42(4):495-498. doi: 10.1111/jcpt.12524. Epub 2017 Apr 10.

PMID:
28393377
14.

Familial Acute Myeloid Leukemia and Myelodysplasia in Hungary.

Király AP, Kállay K, Gángó A, Kellner Á, Egyed M, Szőke A, Kiss R, Vályi-Nagy I, Csomor J, Matolcsy A, Bödör C.

Pathol Oncol Res. 2018 Jan;24(1):83-88. doi: 10.1007/s12253-017-0216-4. Epub 2017 Mar 29.

PMID:
28357685
15.

[The role of driver and subclonal mutations in pathogenesis of primary myelofibrosis].

Mózes R, Gángó A, Boha Z, Csomor J, Bödör C.

Magy Onkol. 2017 Mar 8;61(1):36-45. Epub 2016 Apr 13. Review. Hungarian.

16.

Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim-Chester disease.

Váradi Z, Bánusz R, Csomor J, Kállay K, Varga E, Kertész G, Csóka M.

Onco Targets Ther. 2017 Jan 24;10:521-526. doi: 10.2147/OTT.S121615. eCollection 2017.

17.

[Tocilizumab treatment of HHV8-positive/HIV-negative, multricentric plasma cell type Castleman's disease].

Mûzes G, Csomor J, Sipos F.

Magy Onkol. 2016 Nov 29;60(4):328-332. Epub 2016 Apr 11. Hungarian.

18.

Histopathological aspects and differential diagnosis of CD8 positive lymphomatoid papulosis.

Marschalkó M, Gyöngyösi N, Noll J, Károlyi Z, Wikonkál N, Hársing J, Kuroli E, Csomor J, Matolcsy A, Sarolta K, Szepesi Á.

J Cutan Pathol. 2016 Nov;43(11):963-973. doi: 10.1111/cup.12779. Epub 2016 Aug 30.

PMID:
27461449
19.

Autochthonous human alveolar echinococcosis in a Hungarian patient.

Dezsényi B, Strausz T, Makrai Z, Csomor J, Danka J, Kern P, Rezza G, Barth TF, Casulli A.

Infection. 2017 Feb;45(1):107-110. doi: 10.1007/s15010-016-0918-7. Epub 2016 Jun 28.

PMID:
27352256
20.

[Novelties in the diagnostics and therapy of hairy cell leukemia].

Sári E, Rajnai H, Dénes K, Bödör C, Csomor J, Körösmezey G, Tárkányi I, Eid H, Nagy Z, Demeter J.

Magy Onkol. 2016 Jun 6;60(2):137-44. Epub 2016 Apr 15. Review. Hungarian.

21.

[Dangerous cucumbers - Leylls syndrome].

Csomor J, Bunganič B, Zakharov S, Pafčuga I, Sedloň P, Urbánek P.

Vnitr Lek. 2016 Jan;62(1):57-61. Czech.

PMID:
26967239
22.

[Clinical and genetic background of familial myelodysplasia and acute myeloid leukemia].

Király PA, Kállay K, Marosvári D, Benyó G, Szőke A, Csomor J, Bödör C.

Orv Hetil. 2016 Feb 21;157(8):283-9. doi: 10.1556/650.2016.30375. Review. Hungarian.

PMID:
26876264
23.

Low CD23 expression correlates with high CD38 expression and the presence of trisomy 12 in CLL.

Kriston C, Bödör C, Szenthe K, Bánáti F, Bánkuti B, Csernus B, Reiniger L, Csomor J, Matolcsy A, Barna G.

Hematol Oncol. 2017 Mar;35(1):58-63. doi: 10.1002/hon.2244. Epub 2015 Jun 29.

PMID:
26119874
24.

Toxic Epidermal Necrolysis After Exposure to Dithiocarbamate Fungicide Mancozeb.

Zakharov S, Csomor J, Urbanek P, Pelclova D.

Basic Clin Pharmacol Toxicol. 2016 Jan;118(1):87-91. doi: 10.1111/bcpt.12430. Epub 2015 Jun 29.

25.

Connexin 43 communication channels in follicular dendritic cell development and in follicular lymphomas.

Rajnai H, Teleki I, Kiszner G, Meggyesházi N, Balla P, Vancsik T, Muzes G, Csomor J, Matolcsy A, Krenacs T.

J Immunol Res. 2015;2015:528098. doi: 10.1155/2015/528098. Epub 2015 Mar 2.

26.

Altered microRNA expression in folliculotropic and transformed mycosis fungoides.

Marosvári D, Téglási V, Csala I, Marschalkó M, Bödör C, Timár B, Csomor J, Hársing J, Reiniger L.

Pathol Oncol Res. 2015 Jul;21(3):821-5. doi: 10.1007/s12253-015-9897-8. Epub 2015 Feb 20.

PMID:
25698383
27.

[Complex molecular genetic algorithm in the diagnosis of myeloproliferative neoplasms].

Krähling T, Balassa K, Meggyesi N, Bors A, Csomor J, Bátai Á, Halm G, Egyed M, Fekete S, Reményi P, Masszi T, Tordai A, Andrikovics H.

Orv Hetil. 2014 Dec 28;155(52):2074-81. doi: 10.1556/OH.2014.30051. Hungarian.

PMID:
25528320
28.

Folliculotropic mycosis fungoides: clinicopathological analysis of 17 patients.

Marschalkó M, Erős N, Kontár O, Hidvégi B, Telek J, Hársing J, Jókai H, Bottlik G, Rajnai H, Szepesi Á, Matolcsy A, Kárpáti S, Csomor J.

J Eur Acad Dermatol Venereol. 2015 May;29(5):964-72. doi: 10.1111/jdv.12743. Epub 2014 Nov 18.

PMID:
25406034
29.

Histopathological difficulties in an adolescent lymphoma patient.

Magyari F, Barna S, Miltényi Z, Rajnai H, Csomor J, Udvardy M, Illés Á, Váróczy L.

Pathol Oncol Res. 2015 Jan;21(1):213-7. doi: 10.1007/s12253-014-9810-x. Epub 2014 Jul 2.

PMID:
24985032
30.

Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations.

Andrikovics H, Krahling T, Balassa K, Halm G, Bors A, Koszarska M, Batai A, Dolgos J, Csomor J, Egyed M, Sipos A, Remenyi P, Tordai A, Masszi T.

Haematologica. 2014 Jul;99(7):1184-90. doi: 10.3324/haematol.2014.107482. Epub 2014 Jun 3.

31.

Treatment of refractory hairy cell leukemia with a BRAF-inhibitor: lessons to be learnt.

Sári E, Nagy ZG, Baghy K, Rajnai H, Bödör C, Csomor J, Barna G, Rudas G, Kovalszky I, Demeter J.

Pathol Oncol Res. 2014 Oct;20(4):973-80. doi: 10.1007/s12253-014-9783-9. Epub 2014 May 3.

PMID:
24789721
32.

Unicentric mixed variant Castleman disease associated with intrabronchial plasmacytoma.

Eszes N, Tamási L, Csekeő A, Csomor J, Szepesi A, Varga G, Balázs G, Losonczy G, Müller V.

Diagn Pathol. 2014 Mar 20;9:64. doi: 10.1186/1746-1596-9-64.

33.

Molecular cytogenetic analysis of Xq critical regions in premature ovarian failure.

Beke A, Piko H, Haltrich I, Csomor J, Matolcsy A, Fekete G, Rigo J, Karcagi V.

Mol Cytogenet. 2013 Dec 20;6(1):62. doi: 10.1186/1755-8166-6-62.

34.

Successful treatment of renal failure caused by multiple myeloma with HLA-identical living kidney and bone marrow transplantation: a case report.

Wagner L, Lengyel L, Mikala G, Reményi P, Piros L, Csomor J, Fábry L, Tordai A, Langer RM, Masszi T.

Transplant Proc. 2013;45(10):3705-7. doi: 10.1016/j.transproceed.2013.10.005.

PMID:
24315003
35.

Sarcoidosis lymphoma syndrome - the value of PET-CT in the diagnosis.

Kis A, Eszes N, Tamasi L, Losonczy G, Csekeo A, Csomor J, Muller V.

World J Surg Oncol. 2013 Sep 18;11:235. doi: 10.1186/1477-7819-11-235.

36.

[Clinical observations in cutan mastocytosis].

Mihalik N, Hidvégi B, Hársing J, Várkonyi J, Csomor J, Kovalszky I, Marschalkó M, Kárpáti S.

Orv Hetil. 2013 Sep 15;154(37):1469-75. doi: 10.1556/OH.2013.29702. Hungarian.

PMID:
24016753
37.

Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease--a combined tissue microarray, in vitro and in vivo study.

Márk Á, Hajdu M, Váradi Z, Sticz TB, Nagy N, Csomor J, Berczi L, Varga V, Csóka M, Kopper L, Sebestyén A.

BMC Cancer. 2013 May 22;13:250. doi: 10.1186/1471-2407-13-250.

38.

Multicentric Castleman's disease: a challenging diagnosis.

Műzes G, Sipos F, Csomor J, Sréter L.

Pathol Oncol Res. 2013 Jul;19(3):345-51. doi: 10.1007/s12253-013-9619-z. Epub 2013 Mar 21. Review.

PMID:
23516126
39.

Long lasting complete molecular remission after suspending dasatinib treatment in chronic myeloid leukemia.

Gadó K, Matolcsy A, Csomor J, Kicsi D, Bödör C, Domján G.

Exp Hematol Oncol. 2012 Jul 11;1(1):17. doi: 10.1186/2162-3619-1-17.

41.

Comparative analysis of IL6 and IL6 receptor gene polymorphisms in mastocytosis.

Rausz E, Szilágyi A, Nedoszytko B, Lange M, Niedoszytko M, Lautner-Csorba O, Falus A, Aladzsity I, Kokai M, Valent P, Marschalko M, Hidvégi B, Szakonyi J, Csomor J, Várkonyi J.

Br J Haematol. 2013 Jan;160(2):216-9. doi: 10.1111/bjh.12086. Epub 2012 Oct 18.

PMID:
23078005
42.

Type and location of isocitrate dehydrogenase mutations influence clinical characteristics and disease outcome of acute myeloid leukemia.

Koszarska M, Bors A, Feczko A, Meggyesi N, Batai A, Csomor J, Adam E, Kozma A, Orban TI, Lovas N, Sipos A, Karaszi E, Dolgos J, Fekete S, Reichardt J, Lehoczky E, Masszi T, Tordai A, Andrikovics H.

Leuk Lymphoma. 2013 May;54(5):1028-35. doi: 10.3109/10428194.2012.736981. Epub 2012 Nov 6.

PMID:
23039322
43.

Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: report of two cases with no evidence of systemic disease.

Szepesi Á, Csomor J, Rajnai H, Erős N, Wikonkál N, Kárpáti S, Matolcsy A, Marschalkó M.

Eur J Dermatol. 2012 Sep-Oct;22(5):690-1. doi: 10.1684/ejd.2012.1823. No abstract available.

PMID:
22940730
44.

Tissue-specific homing of immune cells in malignant skin tumors.

Jókai H, Marschalkó M, Csomor J, Szakonyi J, Kontár O, Barna G, Kárpáti S, Holló P.

Pathol Oncol Res. 2012 Oct;18(4):749-59. Epub 2012 Apr 24. Review.

PMID:
22528565
45.

Extranodal marginal zone lymphoma of the CNS arising after a long-standing history of atypical white matter disease.

Schiefer AI, Vastagh I, Molnar MJ, Bereczki D, Varallyay G, Deak B, Csomor J, Turanyi E, Kovacs GG, Müllauer L.

Leuk Res. 2012 Jul;36(7):e155-7. doi: 10.1016/j.leukres.2012.03.022. Epub 2012 Apr 18. No abstract available.

PMID:
22520340
46.

Validation of diagnostic accuracy using digital slides in routine histopathology.

Fónyad L, Krenács T, Nagy P, Zalatnai A, Csomor J, Sápi Z, Pápay J, Schönléber J, Diczházi C, Molnár B.

Diagn Pathol. 2012 Mar 31;7:35. doi: 10.1186/1746-1596-7-35.

47.

Morphological differentiation of severe aplastic anaemia from hypocellular refractory cytopenia of childhood: reproducibility of histopathological diagnostic criteria.

Baumann I, Führer M, Behrendt S, Campr V, Csomor J, Furlan I, de Haas V, Kerndrup G, Leguit RJ, De Paepe P, Noellke P, Niemeyer C, Schwarz S.

Histopathology. 2012 Jul;61(1):10-7. doi: 10.1111/j.1365-2559.2011.04156.x. Epub 2012 Mar 28.

PMID:
22458667
48.

Impact of the reactive microenvironment on the bone marrow involvement of follicular lymphoma.

Rajnai H, Bödör C, Balogh Z, Gagyi E, Csomor J, Krenács T, Tóth E, Matolcsy A.

Histopathology. 2012 May;60(6B):E66-75. doi: 10.1111/j.1365-2559.2012.04187.x. Epub 2012 Mar 6.

PMID:
22394030
49.

Persistent agmination of lymphomatoid papulosis: a new case with immunohistopathologically confirmed mycosis fungoides component.

Csomor J, Erős N, Szepesi Á, Csernus B, Szakonyi J, Kontár O, Matolcsy A, Kárpáti S, Marschalkó M.

J Am Acad Dermatol. 2011 Sep;65(3):e98-e100. doi: 10.1016/j.jaad.2011.04.021. No abstract available.

PMID:
21839314
50.

The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemia.

Nahajevszky S, Andrikovics H, Batai A, Adam E, Bors A, Csomor J, Gopcsa L, Koszarska M, Kozma A, Lovas N, Lueff S, Matrai Z, Meggyesi N, Sinko J, Sipos A, Varkonyi A, Fekete S, Tordai A, Masszi T.

Haematologica. 2011 Nov;96(11):1613-8. doi: 10.3324/haematol.2011.043885. Epub 2011 Jul 26.

Supplemental Content

Loading ...
Support Center